# Bracco Diagnostics, Inc clinical trials: 49 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 49 trials with Bracco Diagnostics, Inc as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Bracco Diagnostics, Inc: 49 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/bracco-diagnostics-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 49
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 49, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 6, 2024 | NCT06400004 | Lumason® Infusion vs. Bolus Administrations | Bracco Diagnostics, Inc | Phase 3 | Recruiting | Heart Diseases | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06400004) |
| July 1, 2020 | NCT04453059 | Study With Oral Isovue in Abdominopelvic CT | Bracco Diagnostics, Inc | Observational | Completed | Patients Requiring Abdominopelvic CT With Oral Administration of Contrast | 218 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04453059) |
| January 30, 2020 | NCT04248153 | Optimal Timing of BR55 CEUS of the Ovaries | Bracco Diagnostics, Inc | Phase 2 | Terminated | Ovarian Cancer | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04248153) |
| December 19, 2018 | NCT03779906 | Thyroid Function of Pediatric Subjects Following Isovue® Administration | Bracco Diagnostics, Inc | Phase 4 | Terminated | Hypothyroidism | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03779906) |
| November 21, 2018 | NCT03750188 | Evaluation of Safety and Efficacy of ProHance in Pediatric Patients \<2yrs | Bracco Diagnostics, Inc | Observational | Completed | Central Nervous System Diseases, Central Nervous System Neoplasms | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03750188) |
| April 10, 2018 | NCT03493464 | BR55 in Characterization of Ovarian Lesions | Bracco Diagnostics, Inc | Phase 2 | Terminated | Ovarian Cancer | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03493464) |
| April 3, 2018 | NCT03486327 | Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions | Bracco Diagnostics, Inc | Phase 2 | Terminated | Pancreatic Ductal Adenocarcinoma | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03486327) |
| May 10, 2017 | NCT03147989 | Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients | Bracco Diagnostics, Inc | Observational | Completed | Central Nervous System Diseases, Central Nervous System Neoplasms | 352 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03147989) |
| April 11, 2017 | NCT03108378 | Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control | Bracco Diagnostics, Inc | Observational | Completed | Gadolinium Retention | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03108378) |
| November 4, 2015 | NCT02596048 | A Multicenter Study of Iomeron®-400 Used With Multi-detector Computed Tomography Angiography (MDCTA) | Bracco Diagnostics, Inc | Phase 4 | Completed | Aortic Disorders, Carotid Disease, Pulmonary Disease, Peripheral Artery Disease | 224 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02596048) |
| September 17, 2015 | NCT02552238 | Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142 | Bracco Diagnostics, Inc | Phase 3 | Completed | Coronary Artery Disease | 174 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02552238) |
| August 13, 2015 | NCT02522481 | Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141 | Bracco Diagnostics, Inc | Phase 3 | Completed | Coronary Artery Disease | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02522481) |
| November 17, 2014 | NCT02291822 | Retrospective Study of MRI in Pediatric Patients | Bracco Diagnostics, Inc | Observational | Completed | Central Nervous System Disease, Central Nervous System Neoplasms | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02291822) |
| November 4, 2014 | NCT02282163 | Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography | Bracco Diagnostics, Inc | Phase 3 | Terminated | Heart Disease | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02282163) |
| May 20, 2014 | NCT02142608 | A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer | Bracco Diagnostics, Inc | Phase 1/2 | Completed | Prostate Cancer | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02142608) |
| February 25, 2014 | NCT02070380 | Crossover Comparison of MultiHance and Dotarem | Bracco Diagnostics, Inc | Phase 4 | Completed | Brain Disease | 179 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02070380) |
| November 29, 2012 | NCT01737333 | Multidetector Computed Tomography (MDCT) Tailored Protocol | Bracco Diagnostics, Inc | Observational | Completed | Patients Undergoing Contrast Enhanced Multidetector Computed Tomography of the Chest, Abdomen, Liver or Aorta for Any... | 1,493 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01737333) |
| June 7, 2012 | NCT01613417 | Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain | Bracco Diagnostics, Inc | Phase 4 | Completed | Brain Disease | 229 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01613417) |
| September 9, 2011 | NCT01430975 | Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites | Bracco Diagnostics, Inc | Observational | Completed | Radiation Exposure | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01430975) |
| August 29, 2011 | NCT01424774 | Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning | Bracco Diagnostics, Inc | Observational | Completed | Radiation Exposure | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01424774) |
| March 1, 2011 | NCT01306292 | Safety of SonoVue on Pulmonary Hemodynamics | Bracco Diagnostics, Inc | Phase 2 | Completed | Pulmonary Hypertension | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01306292) |
| December 15, 2010 | NCT01260636 | Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries | Bracco Diagnostics, Inc | Phase 3 | Completed | Carotid, Aortic, Renal or Peripheral Artery Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01260636) |
| December 3, 2010 | NCT01253213 | BR55 in Prostate Cancer: an Exploratory Clinical Trial | Bracco Diagnostics, Inc | Early phase 1 | Completed | Prostate Cancer | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01253213) |
| June 4, 2010 | NCT01137786 | Kidney Damage in Patients With Normal eGFR | Bracco Diagnostics, Inc | Phase 4 | Completed | Coronary Artery Stenosis | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01137786) |
| June 4, 2010 | NCT01136915 | Kidney Damage In Patients With Severe Fall In eGFR | Bracco Diagnostics, Inc | Phase 4 | Terminated | Coronary Artery Stenosis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01136915) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 1 |
| Phase 1/2 | 1 |
| Phase 2 | 5 |
| Phase 3 | 12 |
| Phase 4 | 17 |
| Observational | 12 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 39 |
| Terminated | 9 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Central Nervous System Diseases | 4 |
| Central Nervous System Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Coronary Artery Disease | 3 |
| Coronary Stenosis | 3 |
| Renal Insufficiency | 3 |
| Ovarian Neoplasms | 2 |
| Heart Diseases | 2 |
| Liver Neoplasms | 2 |
| Peripheral Arterial Occlusive Disease 1 | 2 |
| Brain Diseases | 2 |
| Peripheral Arterial Disease | 2 |
| Pulmonary Embolism | 1 |
| Kidney Diseases | 1 |
| Renal Insufficiency, Chronic | 1 |
| Diabetes Mellitus | 1 |
| Hypertension, Pulmonary | 1 |
| Hypothyroidism | 1 |
| Peripheral Vascular Diseases | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Neoplasms | 1 |
| Aortic Diseases | 1 |
| Lung Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Coworking spaces in the United States](https://specstream.ai/data/businesses/coworking-spaces/united-states)
- [Logging contractors in the United States](https://specstream.ai/data/businesses/logging-contractors/united-states)
- [Telecommunications services in the United States](https://specstream.ai/data/businesses/telecommunications-services/united-states)
- [Civil engineering firms in the United States](https://specstream.ai/data/businesses/civil-engineering-firms/united-states)
- [IT service companies in the United States](https://specstream.ai/data/businesses/it-service-companies/united-states)
- [Southern American restaurants in the United States](https://specstream.ai/data/businesses/southern-american-restaurants/united-states)
